CEO SUMMARY: With growing regularity, owners of larger independent clinical laboratories are opting to sell to one of the public lab companies. This time it’s New Hampshire-based Path Lab, which agreed to be acquired by Laboratory Corporation of America. One intriguing aspect of this acquisition is LabCorp’s interest in learning more about PathLab’s successful joint […]
To access this post, you must purchase The Dark Report.